MediciNova (MNOV) Says Results of Phase 2B Trial of MN-221 Didn't Meet Primary Endpoint; to Move Forward with End of Phase Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. MRNA
2. KEYS
3. KLAR
4. PANW
5. SPY
6. MRK
7. HD
8. DVLT
9. NBIS
10. AMLX

Go back to MediciNova (MNOV) Says Results of Phase 2B Trial of MN-221 Didn't Meet Primary Endpoint; to Move Forward with End of Phase Meeting
Medicinova, Inc. (NASDAQ: MNOV) Delayed: 1.38 +0.04 (2.99%)
Previous Close $1.34    52 Week High $10.16 
Open $1.35    52 Week Low $2.91 
Day High $1.39    P/E N/A 
Day Low $1.35    EPS $-0.41 
Volume 55,998